How Has the Peptide Synthesis Market Evolved Historically and What is its Current Size?
The peptide synthesis market has seen considerable growth due to a variety of factors.
• In recent years, there has been robust growth in the size of the peptide synthesis market. It is projected to expand from $5.69 billion in 2024 to $6.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.8%.
The notable growth during the historic period is owed to factors such as the increase in peptide-based vaccines, development in biotechnology and biopharmaceuticals, the demand for high-purity peptides, as well as regulatory approvals and standardization.
What Does Future Hold for The Peptide Synthesis Market By 2029?
The peptide synthesis market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, solid expansion is anticipated in the peptide synthesis market, with its worth estimated to reach $8.9 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%.
The significant growth predicted for this period is due to numerous factors such as the accelerated advancement of therapeutic peptides, escalating requirements for personalize peptides, their escalating involvement in drug discovery and formulation, and the emphasis on peptide libraries for selective screening. Highly regarded trends projected for this span consist of the evolution of peptide analogs, the incorporation of groundbreaking amino acid derivatives, methods for peptide ring formations, advancements in solid-phase peptide synthesis (SPPs), and the application of click chemistry.
What Are The Primary Growth Drivers In The Peptide Synthesis Market?
The peptide synthesis market is projected to grow alongside the escalating prevalence of chronic diseases. Chronic illnesses, also known as non-communicable diseases (NCDs), denote long-term health issues that persist and often gradually progress over time. Chronic diseases can be addressed by peptide synthesis, as some peptides have anti-inflammatory and antioxidant activity, potentially aiding in the prevention of chronic conditions like cardiovascular diseases. Peptides can address the root causes of such diseases by specifically targeting cellular processes and signaling pathways, thereby providing unique treatment and management possibilities. For example, statistics from the Australian Institute of Health and Welfare revealed that in 2022, the standardized death rate due to chronic conditions was 490 per 100,000 people, up from 459 per 100,000 the previous year. The peptide synthesis market is thus bolstered by this increasing number of chronic diseases.
Catalyzing the Peptide Synthesis Market: The Surge in Healthcare Expenditure
What Is The Segmentation Of The Global Peptide Synthesis Market?
The peptide synthesis market covered in this report is segmented –
1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes
Subsegments:
1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents
2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers, Other Analytical Instruments
3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services
Pre-Book The Peptide Synthesis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Peptide Synthesis Market?
Major firms in the peptide synthesis market are striving to gain a competitive advantage by introducing next-generation peptide synthesizers such as the PurePep Sonata+. This advanced synthesizer offers enhanced accuracy, speed, and efficiency compared to its traditional counterparts. For instance, Gyros Protein Technologies, an American peptide synthesis and bioanalytical technology service provider, launched the PurePep Sonata+ peptide synthesizer in March 2022. The PurePep Sonata+ enhances the Sonata XT's functionality by incorporating real-time flow technology, enabling continuous tracking of fluid flow rates within the system. This innovative feature provides a non-invasive method for ensuring accurate and precise fluid transfers for various viscosities.
Who Are the Key Players In The Peptide Synthesis Market?
Major companies operating in the peptide synthesis market report are:
• Thermo Fisher Scientific
• Novo Nordisk A/S
• Merck KGaA
• Lonza Group
• Kaneka Corporation
• Uno Minda
• Guizhou Xinbang Pharmaceutical Co. Ltd.
• Hybio Pharmaceutical Co. Ltd.
• GenScript Biotech
• Bachem Holding AG
• Syngene International
• PolyPeptide Group AG
• Mesa Labs Inc.
• CPC Scientific Inc.
• New England Peptide Inc.
• Biotage
• ScinoPharm Taiwan Ltd.
• MP Biomedicals
• USV Private Limited
• CEM Corporation
• Enamine Ltd.
• Creative Diagnostics
• AnaSpec Inc.
• CSBio Company Inc.
• Alfa Chemistry
• Advanced ChemTech
• Gyros Protein Technologies AB
• AAPPTec LLC
• Biosynth International Inc.
• ProteoGenix
What Are The Regional Insights Into The Peptide Synthesis Market?
North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
